Andere Sprachen Evotec SE

Aktien

566480

DE0005664809

EVT

Biotechnologie

Markt geschlossen - Xetra Andere Börsenplätze 17:35:24 10.07.2026			% 5 Tage	Veränd. 1. Jan.
4,946 ^EUR	-0,88 %		-3,77 %	-9,25 %

30.06.	Evotec erweitert Angebot für vorgefertigte Arzneimittelproduktion	MT
30.06.	Just ? Evotec Biologics bringt mit J.TRAIN eine schlüsselfertige Plattform für kontinuierliche Biologika-Produktion auf den Markt	CI

Andere Sprachen

30.06.	Evotec Expands Prefabricated Drug Manufacturing Offerings
30.06.	Just ? Evotec Biologics Launches J.TRAIN Turnkey Continuous Manufacturing Platform For Biologics
30.06.	Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
16.06.	Evotec SE: Dr. Cord Dohrmann, sell
12.06.	Evotec : Presence and Voting Results AGM 2026 68.764 KB (EVT Abstimmung Liste EN)
11.06.	Evotec Se Announces Board Changes
11.06.	Evotec Reports Results of the Annual General Meeting 2026
02.06.	Evotec Appoints Rui Wang as Head of Global In Silico and AI
02.06.	Evotec SE Appoints Rui Wang as Executive Vice President, Head of Global In Silico and AI
26.05.	Evotec : Letter of the Chair of Supervisory Board to the Shareholders of Evotec 116,952 KB
22.05.	Evotec SE: Dr. Cord Dohrmann, sell
13.05.	Evotec Issues EUR116.1 Million Convertible Bonds Due 2033
12.05.	Evotec SE Successfully Placed €116.1 Million Convertible Bonds
12.05.	Evotec convertible deal expected to price with 2.625% coupon and 37.5% conversion premium, bookrunner says
12.05.	Evotec delta abo total offering size up to c.40 million EUR, bookrunner says
12.05.	Evotec convertible books covered on delta placement ABB (indicated demand exceeds deal size), says bookrunner
12.05.	Evotec launches around EUR 125 mln convertible bond offering
12.05.	Evotec SE launches approximately EUR 125 million convertible bond offering
08.05.	Evotec : Current Company Presentation 1.325 MB (2026 05 EVT Company Presentation)
07.05.	Evotec : Convening and Agenda of the Annual General Meeting, PDF (AGM Agenda EN)
06.05.	Evotec SE Reports Earnings Results for the First Quarter Ended March 31, 2026
06.05.	Evotec : Presentation Analyst Call Q1 2026 results, 6 May 2026 (20260506 Presentation Q1 Results FINAL)
06.05.	Evotec 2026 guidance confirmed
06.05.	Evotec : Interim Statement Q1 2026, PDF (Interim Statement Q1 2026 English)
06.05.	Evotec Announces First Quarter 2026 Results: Building Transformation Momentum